TickerFactsScreenerDevelopers

Arcturus Therapeutics Holdings Inc. (ARCT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$20.76M2019: -$6.45M2020: -$42.86M2021: -$135.04M2022: $31.99M2023: -$18.10M2024: -$59.75M2025: -$74.27M-$74.27M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$74.27M-24.3%
2024-$59.75M-230.1%
2023-$18.10M-156.6%
2022$31.99M+123.7%
2021-$135.04M-215.1%
2020-$42.86M-565.0%
2019-$6.45M+69.0%
2018-$20.76M—